Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Boos

Showing results (251-260 of 257) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 257 results.
British Journal of Haematology|September 21, 2001
Pharmacokinetics of native Escherichia coli asparaginase (Asparaginase medac) and hypersensitivity reactions in ALL-BFM 95 reinduction treatmentH J Müller, R Beier, L Löning, et al.
Klinische Padiatrie|March 18, 2014
Feasibility of intensive multimodal therapy in infants affected by rhabdoid tumors - experience of the EU-RHAB registryA Seeringer, K Bartelheim, K Kerl, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 11, 2024
Poor long-term outcomes and abnormal neurodegeneration biomarkers after military traumatic brain injury: the ADVANCE studyNeil Sn Graham, Grace Blissitt, Karl Zimmerman, et al.
British Journal of Anaesthesia|March 23, 2024
Pain after combat injury in male UK military personnel deployed to AfghanistanJan Vollert, Alexander Kumar, Emma C Coady, et al.
Klinische Padiatrie|August 31, 2001
[Improved treatment results in children with AML: Results of study AML-BFM 93]U Creutzig, F Berthold, J Boos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020
Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HRF Berthold, A Faldum, A Ernst, et al.
Heart (British Cardiac Society)|February 12, 2025
Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trialShirley Sze, Iain Squire, Paul R Kalra, et al.
Pageof 26

Showing results (251-260 of 257) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 257 results.
British Journal of Haematology|September 21, 2001
Pharmacokinetics of native Escherichia coli asparaginase (Asparaginase medac) and hypersensitivity reactions in ALL-BFM 95 reinduction treatmentH J Müller, R Beier, L Löning, et al.
Klinische Padiatrie|March 18, 2014
Feasibility of intensive multimodal therapy in infants affected by rhabdoid tumors - experience of the EU-RHAB registryA Seeringer, K Bartelheim, K Kerl, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 11, 2024
Poor long-term outcomes and abnormal neurodegeneration biomarkers after military traumatic brain injury: the ADVANCE studyNeil Sn Graham, Grace Blissitt, Karl Zimmerman, et al.
British Journal of Anaesthesia|March 23, 2024
Pain after combat injury in male UK military personnel deployed to AfghanistanJan Vollert, Alexander Kumar, Emma C Coady, et al.
Klinische Padiatrie|August 31, 2001
[Improved treatment results in children with AML: Results of study AML-BFM 93]U Creutzig, F Berthold, J Boos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020
Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HRF Berthold, A Faldum, A Ernst, et al.
Heart (British Cardiac Society)|February 12, 2025
Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trialShirley Sze, Iain Squire, Paul R Kalra, et al.
Pageof 26